Evaluation of Retinal Arterial Occlusion and its... (2024 study) Skip to main content
Clinical Study Retina (Philadelphia, Pa.) 2024

Evaluation of Retinal Arterial Occlusion and its Visual and Systemic Prognosis after Hyperbaric Oxygen Therapy.

Kalaw FGP, Chartrand N, Wedekind L, Chen JS, Lin AC, Koretz Z, et al., Retina (Philadelphia, Pa.), 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked at the records of 75 people with a blocked artery in the eye (branch or central retinal artery occlusion) and compared eye and stroke outcomes between those who received hyperbaric oxygen therapy (HBOT) and those who did not.

What They Found

In this single-institution study of 75 people with retinal artery occlusion, HBOT was not linked to a significant change in vision or in later stroke or neovascular glaucoma. Twenty-seven people (36%) received HBOT when they first came in. Vision did not change from the first visit to the final timepoint in either group. For central occlusion, vision scores were 2.1 versus 2.2 without HBOT (p=0.755) and 2.1 versus 2.0 with HBOT (p=0.631). For branch occlusion, they were 0.4 versus 0.6 without HBOT (p=0.658) and 0.1 versus 0.4 with HBOT (p=0.207). Seven people (9.3%) had a stroke and five (6.7%) developed neovascular glaucoma, with no significant differences between the groups.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a single-institution study that compared people who did and did not receive HBOT without random assignment, and the abstract reports no significant differences in any outcome, so it cannot show that HBOT has no effect in every patient.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 39163734
Year Published 2024
Journal Retina (Philadelphia, Pa.)

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology